Kaye Mark — SEC Form 4 filings
SEC reporting owner CIK 1748691. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-03.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-03-05 to 2026-06-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 4,588 shares, $1,949,074 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 4,588 shares @ $424.82 ($1,949,074) in Elevance Health, Inc., filed 2025-04-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Elevance Health, Inc. (ELV) | EVP & CFO | 6 | — | 1 leg · 4,588 sh · $1,949,074 | 12 |
| CONMED Corp (CNMD) | Director | 4 | — | — | 9 |
Form 4 filings — Kaye Mark
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-03 | 4 | CONMED Corp (CNMD) | Option exercise (M): 668 @ $0 · Grant/award (A): 5,772 (derivative) @ $0 · Option exercise (M): 668 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Elevance Health, Inc. (ELV) | Tax withholding (F): 271 @ $294.07 · Grant/award (A): 6,377 @ $0 · Grant/award (A): 10,202 @ $0 · Tax withholding (F): 353 @ $284.03 · Grant/award (A): 25,188 (derivative) @ $0 | EDGAR |
| 2026-02-26 | 4 | CONMED Corp (CNMD) | Option exercise (M): 152 @ $0 · Option exercise (M): 152 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | Elevance Health, Inc. (ELV) | Tax withholding (F): 2,895 @ $340.24 | EDGAR |
| 2025-06-04 | 4 | CONMED Corp (CNMD) | Grant/award (A): 8,061 (derivative) @ $0 · Grant/award (A): 668 (derivative) @ $0 | EDGAR |
| 2025-04-25 | 4 | Elevance Health, Inc. (ELV) | Sale (S): 4,588 @ $424.82 | EDGAR |
| 2025-03-05 | 4 | Elevance Health, Inc. (ELV) | Tax withholding (F): 270 @ $395.50 · Grant/award (A): 3,604 @ $0 · Grant/award (A): 13,713 (derivative) @ $0 | EDGAR |
| 2025-02-26 | 4 | CONMED Corp (CNMD) | Grant/award (A): 1,846 (derivative) @ $0 · Grant/award (A): 152 (derivative) @ $0 | EDGAR |
| 2024-10-04 | 4 | Elevance Health, Inc. (ELV) | Tax withholding (F): 2,818 @ $505.16 | EDGAR |
| 2024-03-05 | 4 | Elevance Health, Inc. (ELV) | Grant/award (A): 2,755 @ $0 · Grant/award (A): 10,633 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1748691 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →